126 related articles for article (PubMed ID: 12878823)
1. Hypericin as novel and promising photodynamic therapy tool: studies on intracellular accumulation capacity and growth inhibition efficiency.
Luksiene Z; de Witte PA
Medicina (Kaunas); 2003; 39(7):677-82. PubMed ID: 12878823
[TBL] [Abstract][Full Text] [Related]
2. Cytosolic superoxide dismutase activity after photodynamic therapy, intracellular distribution of Photofrin II and hypericin, and P-glycoprotein localization in human colon adenocarcinoma.
Saczko J; Kulbacka J; Chwilkowsa A; Pola A; Lugowski M; Marcinkowska A; Malarska A; Banas T
Folia Histochem Cytobiol; 2007; 45(2):93-8. PubMed ID: 17597022
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
Boiy A; Roelandts R; de Witte PA
J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
[TBL] [Abstract][Full Text] [Related]
4. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model.
Chen B; Xu Y; Roskams T; Delaey E; Agostinis P; Vandenheede JR; de Witte P
Int J Cancer; 2001 Jul; 93(2):275-82. PubMed ID: 11410877
[TBL] [Abstract][Full Text] [Related]
6. Experimental evidence on possibility to radiosensitize aggressive tumors by porphyrins.
Luksiene Z
Medicina (Kaunas); 2004; 40(9):868-74. PubMed ID: 15456974
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro study on the characteristics of different photosensitizers employed in PDT.
Berlanda J; Kiesslich T; Engelhardt V; Krammer B; Plaetzer K
J Photochem Photobiol B; 2010 Sep; 100(3):173-80. PubMed ID: 20599390
[TBL] [Abstract][Full Text] [Related]
8. Cellular photodestruction induced by hypericin in AY-27 rat bladder carcinoma cells.
Kamuhabwa AR; Agostinis PM; D'Hallewin MA; Baert L; de Witte PA
Photochem Photobiol; 2001 Aug; 74(2):126-32. PubMed ID: 11547545
[TBL] [Abstract][Full Text] [Related]
9. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin.
Alecu M; Ursaciuc C; Hãlãlãu F; Coman G; Merlevede W; Waelkens E; de Witte P
Anticancer Res; 1998; 18(6B):4651-4. PubMed ID: 9891535
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model.
Chen B; de Witte PA
Cancer Lett; 2000 Mar; 150(1):111-7. PubMed ID: 10755394
[TBL] [Abstract][Full Text] [Related]
12. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma.
Sanovic R; Verwanger T; Hartl A; Krammer B
Photodiagnosis Photodyn Ther; 2011 Dec; 8(4):291-6. PubMed ID: 22122915
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy of murine fibrosarcoma with topical and systemic administration of hypericin.
Cavarga I; Brezáni P; Cekanová-Figurová M; Solár P; Fedorocko P; Miskovský P
Phytomedicine; 2001 Sep; 8(5):325-30. PubMed ID: 11695874
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
Lilge L; Wilson BC
J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy - hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity.
Plenagl N; Duse L; Seitz BS; Goergen N; Pinnapireddy SR; Jedelska J; Brüßler J; Bakowsky U
Drug Deliv; 2019 Dec; 26(1):23-33. PubMed ID: 30691327
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
Du HY; Bay BH; Olivo M
Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
[TBL] [Abstract][Full Text] [Related]
18. Topical treatment of disseminated superficial actinic porokeratosis with hypericin-photodynamic therapy: a case report.
Boiy A; de Witte PA; Roelandts R
Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):123-5. PubMed ID: 20510308
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma.
Chung PS; Rhee CK; Kim KH; Paek W; Chung J; Paiva MB; Eshraghi AA; Castro DJ; Saxton RE
Laryngoscope; 2000 Aug; 110(8):1312-6. PubMed ID: 10942132
[TBL] [Abstract][Full Text] [Related]
20. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
Höpfner M; Maaser K; Theiss A; Lenz M; Sutter AP; Kashtan H; von Lampe B; Riecken EO; Zeitz M; Scherübl H
Int J Colorectal Dis; 2003 May; 18(3):239-47. PubMed ID: 12673490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
